Dana Investment Advisors Inc. purchased a new stake in Insmed Incorporated (NASDAQ:INSM – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 15,365 shares of the biopharmaceutical company’s stock, valued at approximately $388,000. Other hedge funds also recently made changes to their positions […]